Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya

Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya

Bibliographic Details
Main Authors:	Watsierah, Carren A, Onyango, Rosebella O, Ombaka, James H, Abong’o, Benard O, Ouma, Collins
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544597/

Similar Items

Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya
by: Watsierah, Carren A, et al.
Published: (2011)

Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya
by: Watsierah, Carren A, et al.
Published: (2014)

A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
by: Agarwal, Aarti, et al.
Published: (2013)

Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya
by: Onyango, Elizabeth O, et al.
Published: (2012)

Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children
by: Yeka, Adoke, et al.
Published: (2013)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
by: Sudoi, Raymond K, et al.
Published: (2012)

Efficiency and factors influencing efficiency of Community Health Strategy in providing Maternal and Child Health services in Mwingi District, Kenya: an expert opinion perspective
by: Nzioki, Japheth Mativo, et al.
Published: (2015)

Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial
by: Muehlenbachs, Atis, et al.
Published: (2012)

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
by: Tarning, Joel, et al.
Published: (2013)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
by: Mugoyela, V, et al.
Published: (2011)

Systematic Monitoring of Male Circumcision Scale-Up in Nyanza, Kenya: Exploratory Factor Analysis of Service Quality Instrument and Performance Ranking
by: Omondi Aduda, Dickens S., et al.
Published: (2014)

Voluntary Medical Male Circumcision Scale-Up in Nyanza, Kenya: Evaluating Technical Efficiency and Productivity of Service Delivery
by: Omondi Aduda, Dickens S., et al.
Published: (2015)

Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
by: Achieng, Angela O., et al.
Published: (2015)

Determinants of Cervical screening services uptake among 18–49 year old women seeking services at the Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
by: Morema, Everlyne N, et al.
Published: (2014)

Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia
by: Lemma, Hailemariam, et al.
Published: (2011)

Sustained-release liquisolid compact tablets containing artemether–lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance
by: Nnamani, Petra Obioma, et al.
Published: (2016)

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens
by: Kapisi, James, et al.
Published: (2015)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial
by: Kamya, Moses R, et al.
Published: (2007)

The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya
by: Wasunna, Beatrice, et al.
Published: (2015)

State of the Globe: Tracking Tuberculosis is the Test of Time
by: Onyango, Rosebella O
Published: (2011)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
by: Tchaparian, Eskouhie, et al.
Published: (2016)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
by: Prah, James, et al.
Published: (2016)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
by: Bassat, Quique
Published: (2011)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
by: Chanda, Pascalina, et al.
Published: (2007)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
by: Repetto, Ernestina C., et al.
Published: (2011)

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
by: Rulisa, Stephen, et al.
Published: (2012)

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
by: Staehli Hodel, Eva Maria, et al.
Published: (2013)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: Patel, A., et al.
Published: (2012)

Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
by: Mosha, Dominic, et al.
Published: (2014)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
by: Liusheng Huang, et al.

Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children
by: Dambe, Rosalia, et al.
Published: (2015)

A dietary strategy for the management of artemether-lumefantrine-induced cardiovascular and renal toxicity
by: Asiedu-Gyekye, Isaac Julius, et al.
Published: (2016)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
by: Ogouyèmi-Hounto, Aurore, et al.
Published: (2016)

A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
by: Makanga, Michael
Published: (2014)

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia
by: Manyando, Christine, et al.
Published: (2015)

Quality and stability of artemether-lumefantrine stored under ambient conditions in rural Mali
by: Gitua, John, et al.
Published: (2014)

Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia
by: Tiono, Alfred B., et al.
Published: (2013)

A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
by: Makanga, Michael
Published: (2014)